Viral infection of the lungs through the eye

Journal of Virology

Volumn 81, Issue 2, 2007, Pages 783-790

  Bitko, Vira ^a   Musiyenko, Alla ^a   Barik, Sailen ^a  

^a UNIVERSITY OF SOUTH ALABAMA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; INTERLEUKIN 1ALPHA; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC CONJUNCTIVITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; EYE INFECTION; FEMALE; LUNG INFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; VIROGENESIS; VIRUS INFECTION; VIRUS PATHOGENESIS; VIRUS REPLICATION;

ANIMALS; ANTIBODIES, MONOCLONAL; CONJUNCTIVITIS, VIRAL; DISEASE MODELS, ANIMAL; EYE; FEMALE; HUMANS; INTERLEUKIN-1ALPHA; LUNG; MICE; MICE, INBRED BALB C; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; RESPIRATORY TRACT INFECTIONS; RNA, SMALL INTERFERING; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA; VIRUS REPLICATION;

MURINAE; RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS;

EID: 33846106823     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01437-06     Document Type: Article

References (45)

1. Adamus, G., M. Manczak, and M. Machnicki. 2001. Expression of CC chemokines and their receptors in the eye in autoimmune anterior uveitis associated with EAE. Investig. Ophthalmol. Vis. Sci. 42:2894-2903.
2. Barik, S. 2004. Control of nonsegmented negative-strand RNA virus replication by siRNA. Virus Res. 102:27-35.
3. Barik, S. 2005. Silence of the transcripts: RNA interference in medicine. J. Mol. Med. 83:764-773.
4. Bitko, V., and S. Barik. 2001. Phenotypic silencing of cytoplasmic genes using sequence-specific double-stranded short interfering RNA and its application in the reverse genetics of wild type negative-strand RNA viruses. BMC Microbiol. 1:34.
5. Bitko, V., N. E. Garmon, T. Cao, B. Estrada, J. E. Oakes, R. N. Lausch, and S. Barik. 2004. Activation of cytokines and NF-kappa B in corneal epithelial cells infected by respiratory syncytial virus: potential relevance in ocular inflammation and respiratory infection. BMC Microbiol. 4:28.
6. Bitko, V., A. Musiyenko, O. Shulyayeva, and S. Barik. 2005. Inhibition of respiratory viruses by nasally administered siRNA. Nat. Med. 11:50-55.
7. Bitko, V., A. Velazquez, L. Yang, Y. C. Yang, and S. Barik. 1997. Transcriptional induction of multiple cytokines by human respiratory syncytial virus requires activation of NF-kappa B and is inhibited by sodium salicylate and aspirin. Virology 232:369-378.
8. Brandt, C. R. 2005. The role of viral and host genes in corneal infection with herpes simplex virus type 1. Exp. Eye Res. 80:607-621.
9. Brito, B. E., L. M. O'Rourke, Y. Pan, J. Anglin, S. R. Planck, and J. T. Rosenbaum. 1999. IL-1 and TNF receptor-deficient mice show decreased inflammation in an immune complex model of uveitis. Investig. Ophthalmol. Vis. Sci. 40:2583-2589.
10. Chavez-Bueno, S., A. Mejias, A. M. Gomez, K. D. Olsen, A. M. Rios, M. Fonseca-Aten, O. Ramilo, and H. S. Jafri. 2005. Respiratory syncytial virus-induced acute and chronic airway disease is independent of genetic background: an experimental murine model. Virol. J. 2:46.
11. Chavez-Bueno, S., A. Mejias, H. S. Jafri, and O. Ramilo. 2005. Respiratory syncytial virus: old challenges and new approaches. Pediatr. Ann. 34:62-68.
12. Christopherson, K., II, and R. Hromas. 2001. Chemokine regulation of normal and pathologic immune responses. Stem Cells 19:388-396.
13. Collins, P. L., and B. R. Murphy. 2002. Respiratory syncytial virus: reverse genetics and vaccine strategies. Virology 296:204-211.
14. Dakhama, A., Y. M. Lee, and E. W. Gelfand. 2005. Virus-induced airway dysfunction: pathogenesis and biomechanisms. Pediatr. Infect. Dis. J. 24(Suppl. 11):S159-S169.
15. Frieri, M. 2004. Airway epithelial cell release of cytokines: modulation by various therapeutic agents. Allergy Asthma Proc. 25:387-393.
16. Fujishima, H., Y. Okamoto, L. Saito, and K. Tsubota. 1995. Respiratory syncytial virus and allergic conjunctivitis. J. Allergy Clin. Immunol. 95:663-667.
17. Gala, C. L., C. B. Hall, K. C. Schnabel, P. H. Pincus, P. Blossom, S. W. Hildreth, R. F. Betts, and R. G. Douglas, Jr. 1986. The use of eye-nose goggles to control nosocomial respiratory syncytial virus infection. JAMA 256:2706-2708.
18. Girgis, D. O., G. D. Sloop, J. M. Reed, and R. J. O'Callaghan. 2003. A new topical model of Staphylococcus corneal infection in the mouse. Investig. Ophthalmol. Vis. Sci. 44:1591-1597.
19. Grunweller, A., and R. K. Hartmann. 2005. RNA interference as a gene-specific approach for molecular medicine. Curr. Med. Chem. 12:3143-3161.
20. Hall, C. B., R. G. Douglas, Jr., K. C. Schnabel, and J. M. Geiman. 1981. Infectivity of respiratory syncytial virus by various routes of inoculation. Infect. Immun. 33:779-783.
21. Hong, J. W., J. J. Liu, J. S. Lee, R. R. Mohan, R. R. Mohan, D. J. Woods, Y. G. He, and S. E. Wilson. 2001. Proinflammatory chemokine induction in keratocytes and inflammatory cell infiltration into the cornea. Investig. Ophthalmol. Vis. Sci. 42:2795-2803.
22. Hussell, T., A. Pennycook, and P. J. Openshaw. 2001. Inhibition of tumor necrosis factor reduces the severity of virus-specific lung immunopathology. Eur. J. Immunol. 31:2566-2573.
23. Jafri, H. S., S. Chavez-Bueno, A. Mejias, A. M. Gomez, A. M. Rios, S. S. Nassi, M. Yusuf, P. Kapur, R. D. Hardy, J. Hatfield, B. B. Rogers, K. Krisher, and O. Ramilo. 2004. Respiratory syncytial virus induces pneumonia, cytokine response, airway obstruction, and chronic inflammatory infiltrates associated with long-term airway hyperresponsiveness in mice. J. Infect. Dis. 189:1856-1865.
24. Keadle, T. L., N. Usui, K. A. Laycock, J. K. Miller, J. S. Pepose, and P. M. Stuart. 2000. IL-1 and TNF-alpha are important factors in the pathogenesis of murine recurrent herpetic stromal keratitis. Investig. Ophthalmol. Vis. Sci. 41:96-102.
25. Khvorova, A., A. Reynolds, and S. D. Jayasena. 2003. Functional siRNAs and miRNAs exhibit strand bias. Cell 115:209-216. (Erratum 115:505.)
26. Le, G. T., and G. Abbenante. 2005. Inhibitors of TACE and caspase-1 as anti-inflammatory drugs. Curr. Med. Chem. 12:2963-2977.
27. Li, X. Q., Z. F. Fu, R. Alvarez, C. Henderson, and R. A. Tripp. 2006. Respiratory syncytial virus (RSV) infects neuronal cells and processes that innervate the lung by a process involving RSV G protein. J. Virol. 80:537-540.
28. Lundberg, P., and E. Cantin. 2003. A potential role for CXCR3 chemokines in the response to ocular HSV infection. Curr. Eye Res. 26:137-150.
29. Maggon, K., and S. Barik. 2004. New drugs and treatment for respiratory syncytial virus. Rev. Med. Virol. 14:149-168.
30. Mastronarde, J. G., B. He, M. M. Monick, N. Mukaida, K. Matsushima, and G. W. Hunninghake. 1996. Induction of interleukin (IL)-8 gene expression by respiratory syncytial virus involves activation of nuclear factor (NF)-kappa B and NF-IL-6. J. Infect. Dis. 174:262-267.
31. Mastronarde, J. G., M. M. Monick, N. Mukaida, K. Matsushima, and G. W. Hunninghake. 1998. Activator protein-1 is the preferred transcription factor for cooperative interaction with nuclear factor-kappaB in respiratory syncytial virus-induced interleukin-8 gene expression in airway epithelium. J. Infect. Dis. 177:1275-1281.
32. Miles, D. H., M. D. Willcox, and S. Athnunathan. 2004. Ocular and neuronal cell apoptosis during HSV-1 infection: a review. Curr. Eye. Res. 29:79-90.
33. Moore, J. E., T. C. McMullen, I. L. Campbell, R. Rohan, Y. Kaji, N. A. Afshari, T. Usui, D. B. Archer, and A. P. Adamis. 2002. The inflammatory milieu associated with conjuctivalized cornea and its alteration with IL-1 RA gene therapy. Investig. Ophthalmol. Vis. Sci. 43:2905-2915.
34. Murdoch, C., and A. Finn. 2000. Chemokine receptors and their role in inflammation and infectious diseases. Blood 95:3032-3043.
35. Richmond, A. 2002. NF-kappa B, chemokine gene transcription and tumour growth. Nat. Rev. Immunol. 2:664-674.
36. Rossi, D., and A. Zlotnik. 2000. The biology of chemokines and their receptors. Annu. Rev. Immunol. 18:217-242.
37. Schwarz, D. S., G. Hutvagner, T. Du, Z. Xu, N. Aronin, and P. D. Zamore. 2003. Asymmetry in the assembly of the RNAi enzyme complex. Cell 115: 199-208.
38. Stevens, T. P., and C. B. Hall. 2004. Controversies in palivizumab use. Pediatr. Infect. Dis. J. 23:1051-1052.
39. Taylor, P. C., and M. Feldmann. 2004. New approaches to therapeutic immunomodulation for immune-mediated inflammatory disorders. Curr. Opin. Pharmacol. 4:368-371.
40. Tian, B., Y. Zhang, B. A. Luxon, R. P. Garofalo, A. Casola, M. Sinha, and A. R. Brasier. 2002. Identification of NF-κB-dependent gene networks in respiratory syncytial virus-infected cells. J. Virol. 76:6800-6814.
41. Tripp, R. A., C. Oshansky, and R. Alvarez. 2005. Cytokines and respiratory syncytial virus infection. Proc. Am. Thorac. Soc. 2:147-149.
42. Tumpey, T. M., H. Cheng, D. N. Cook, O. Smithies, J. E. Oakes, and R. N. Lausch. 1998. Absence of macrophage inflammatory protein-1α prevents the development of blinding herpes stromal keratitis. J. Virol. 72:3705-3710.
43. Urnowey, S., T. Ansai, V. Bitko, K. Nakayama, T. Takehara, and S. Barik. 2006. Temporal activation of anti- and pro-apoptotic factors in human gingival fibroblasts infected with the periodontal pathogen, Porphyromonas gingivalis: potential role of bacterial proteases in host signalling. BMC Microbiol. 6:26.
44. Wallace, G. R., S. John Curnow, K. Wloka, M. Salmon, and P. I. Murray. 2004. The role of chemokines and their receptors in ocular disease. Prog. Retin. Eye. Res. 23:435-448.
45. Wilson, S. E., Y. G. He, J. Weng, Q. Li, A. W. McDowall, M. Vital, and E. L. Chwang. 1996. Epithelial injury induces keratocyte apoptosis: hypothesized role for the interleukin-1 system in the modulation of corneal tissue organization and wound healing. Exp. Eye Res. 62:325-327.